In the middle of the pandemic, Wistar graduate student Kevin Alicea-Torres is living a busy and exciting life, preparing to defend his thesis and graduate with a Ph.D. in cell and molecular biology from the University of Pennsylvania at the end of…
In mere weeks, philanthropic support of Wistar’s Coronavirus Discovery Fund has exceeded $1.6M in new funding thanks to an extraordinary response from individuals, foundations, and corporate sponsors. As our scientists focused their rese…
Dr. Ertl is a global leader in Wistar’s Vaccine & Immunotherapy Center whose research focuses on preventing rabies, HBV, HIV, HPV, influenza, and other deadly viruses using innovative patented technologies. In response to the global COVID-19 e…
The Pennsylvania Cancer Alliance, a coalition of the state’s leading cancer research institutions, meets every year in early May for a lobbying initiative to engage legislators and spotlight the impact the Commonwealth Universal Research Enhanceme…
PHILADELPHIA — (May, 1, 2020) — The Wistar Institute, an international biomedical research leader in cancer, immunology and infectious diseases, announces the appointment of molecular systems biologist Bin Tian, Ph.D., as professor in the Cancer C…
PHILADELPHIA — (April 29, 2020) — The Wistar Institute and Batavia Biosciences announce the launch of a strategic collaboration aimed to streamline the clinical grade manufacture and global distribution of Wistar’s rubella vaccine seed stock commo…
This is week six of the stay-at-home order in Pennsylvania and Darien Sutton, associate director of Communications & Marketing, caught up again with President and CEO Dario C. Altieri, M.D., for their second virtual chat about what’s going on …
Dr. Luis Montaner is an HIV expert focused on finding new ways to boost the natural function of the immune system to combat infection or viral-associated disease. Dr. Joseph Salvino is a medicinal chemist and an expert in drug discovery and identi…
Principal investigator Dr. Daniel Kulp is one of a group of Wistar scientists undertaking coronavirus research in response to the pandemic. A protein engineering expert, his lab focuses on rational vaccine and therapeutic antibody design for a var…
The Immunology, Microenvironment and Metastasis (IMM) Program explores the basic mechanisms of host-tumor interactions, immune responses and metastatic dissemination to create novel translational avenues for cancer diagnosis and therapy such as im…
